piribedil has been researched along with Brain Neoplasms in 1 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dechaume, JP | 1 |
Lecuire, J | 1 |
Fourcade, C | 1 |
El Quarzazi, A | 1 |
Rossi, A | 1 |
1 other study available for piribedil and Brain Neoplasms
Article | Year |
---|---|
[Clinical and pharmacological studies on a therapy of cerebral ischemia in neurosurgical practice].
Topics: Adult; Aged; Animals; Brain; Brain Edema; Brain Injuries; Brain Neoplasms; Cerebrovascular Circulati | 1976 |